NCT07724106 — West China Hospital cancer vaccine trial
A Single-Arm, Open-Label, Prospective Study Evaluating the Safety, Tolerability, and Immunogenicity of the NeoOVSV Vaccine in Patients With Ovarian Cancer After Surgery
Registry record
| Registry ID | NCT07724106 ↗ |
|---|---|
| Lead sponsor | West China Hospital |
| Collaborators | — |
| Phase | Phase 1 |
| Status | Not Yet Recruiting |
| Indication | Ovarian Cancer, mRNA Vaccine |
| Enrollment | 9 participants (target) |
| Start date | 2026-07-31 |
| Primary completion | 2028-05-01 (est.) |
| Last registry update | 23 Jul 2026 |
Every field above is mirrored from the study record on ClinicalTrials.gov (NCT07724106), which the sponsor maintains and which carries the full protocol summary, eligibility criteria, sites and contacts. No neoantigen vaccine is approved anywhere yet — every program here is investigational, and inclusion is not an endorsement. See the methodology for how the tracker is built.
Where this fits
Daily coverage of the modality, tumor type and players this study touches:
Related trials
FAQ
What phase is NCT07724106?
NCT07724106 (A Single-Arm, Open-Label, Prospective Study Evaluating the Safety, Tolerability, and Immunogenicity of the NeoOVSV Vaccine in Patients With Ovarian Cancer After Surgery) is registered on ClinicalTrials.gov as Phase 1, sponsored by West China Hospital.
Is NCT07724106 recruiting?
As of the 2026-07-23 registry update, NCT07724106 is listed as "Not Yet Recruiting". Eligibility criteria, study sites and contacts are maintained by the sponsor on the ClinicalTrials.gov record.
Who is running NCT07724106?
The lead sponsor is West China Hospital.
What condition does NCT07724106 study?
The registered conditions are Ovarian Cancer, mRNA Vaccine. Primary completion is listed as 2028-05-01 (estimated).
Are results available for NCT07724106?
neoag.ai mirrors the registry's factual fields — sponsor, phase, status and dates — and does not publish trial results. Any posted results, publications, or outcome measures appear on the ClinicalTrials.gov record for NCT07724106.
Back to the full neoantigen vaccine trial tracker — 107 studies, refreshed daily from ClinicalTrials.gov. Background: primer, glossary, and the companies landscape.